Drug Response Study of Leukemia Subtypes Advances Precise Patient-Therapy Matching
A study by researchers at St. Jude Children’s Research Hospital delving into drug response across a swath of genetic subtypes of acute lymphoblastic leukemia (ALL), could provide a map for clinicians to more precisely match available treatments with a patient’s specific form of cancer.
Comments